This edition of the Journal of Clinical Investigation marks the transition to a new editorial team from Johns Hopkins University. It is with great humility and excitement that we assume the mantle of the leading translational science journal in the world and the flagship of the American Society for Clinical Investigation.
Gordon F. Tomaselli
L’dor vador, transliterated from the Hebrew above, is an ancient concept in Judaic scripture meaning “from generation to generation,” which is now generally interpreted to mean that we have a responsibility to pass on teachings to future generations. It has been 5 years that I have been at the helm of the Duke-UNC Editorial Board of the
Howard A. Rockman
Much has been written already about whether the scientific machine is churning out too many PhDs and postdocs when there are a limited number of academic jobs and the competition for funding and space in competitive journals is intense. But gratifyingly, there exists a vast array of other scientific careers. We need to mentor and advise trainees about the diverse and rewarding professional opportunities that are available beyond the postdoctoral apprenticeship period.
Ushma S. Neill
As Editor of the
Howard A. Rockman
In recent years, questions have been raised regarding the failure of some preclinical work to translate to clinical benefit and the inability to reproduce some high-profile studies. While myriad factors contribute to these problems, an important step in improving the integrity of published work is for journals to enforce rigorous reporting of methods and results.
Sarah Jackson
On the occasion of the ninetieth anniversary of the
Howard A. Rockman
As of the writing of this Editorial, the current
Howard A. Rockman
As I draft this editorial, it is almost a year into our stewardship as editors of the
Howard A. Rockman
With the December issue of the Journal of Clinical Investigation, I announce the launch of a new category of manuscript called “Clinical Medicine,” along with new editorial board members to adjudicate the peer-review process. With this initiative, the journal aims to publish the highest quality human research that reports early-stage, effective new therapies that impact disease outcomes.
Howard A. Rockman
No posts were found with this tag.